We are live on ! Find out more
PD

Point72 (DIFC) Portfolio holdings

AUM $1.53B
1-Year Est. Return 15.83%
This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+15.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.95B
AUM Growth
+$144M
Cap. Flow
-$23.5M
Cap. Flow %
-0.8%
Top 10 Hldgs %
11.52%
Holding
1,955
New
543
Increased
368
Reduced
465
Closed
567

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$32M
2
MCK icon
McKesson
MCK
+$30.8M
3
BRKR icon
Bruker
BRKR
+$29.8M
4
QGEN icon
Qiagen
QGEN
+$28.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.7M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$35.9M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30M
3
RTX icon
RTX Corp
RTX
+$28.2M
4
AMZN icon
Amazon
AMZN
+$27.3M
5
PFE icon
Pfizer
PFE
+$25.9M

Sector Composition

Rank Sector Weight
1 Healthcare 13.4%
2 Technology 6.59%
3 Consumer Discretionary 5.03%
4 Industrials 4.98%
5 Financials 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRGV icon
1351
Energy Vault
NRGV
$531M
$385 ﹤0.01%
401
-7,199
-95% -$7.24K
DSGN icon
1352
Design Therapeutics
DSGN
$742M
$362 ﹤0.01%
+67
New +$315
SMXT icon
1353
Solarmax Technology
SMXT
$19.1M
$354 ﹤0.01%
+561
New +$1.48K
ONL
1354
Orion Office REIT
ONL
$150M
$300 ﹤0.01%
+75
New +$294
SAND
1355
DELISTED
Sandstorm Gold
SAND
$294 ﹤0.01%
49
-3,994
-99% -$22.7K
QURE icon
1356
uniQure
QURE
$2.63B
$261 ﹤0.01%
53
OBDC icon
1357
Blue Owl Capital
OBDC
$5.42B
$242 ﹤0.01%
17
CLPT icon
1358
ClearPoint Neuro
CLPT
$438M
$224 ﹤0.01%
20
-5,990
-100% -$57.4K
MGX icon
1359
Metagenomi Therapeutics
MGX
$45.6M
$210 ﹤0.01%
97
-2,198
-96% -$7.63K
SGML icon
1360
Sigma Lithium
SGML
$1.12B
$200 ﹤0.01%
16
-3,987
-100% -$43.5K
PDSB icon
1361
PDS Biotechnology
PDSB
$38.7M
$191 ﹤0.01%
50
-5,030
-99% -$16.8K
HDSN
1362
Hudson Technologies
HDSN
$263M
$176 ﹤0.01%
21
-6,181
-100% -$51.1K
OBK icon
1363
Origin Bancorp
OBK
$1.66B
$161 ﹤0.01%
+5
New +$163
CAMT icon
1364
Camtek
CAMT
$7.07B
$160 ﹤0.01%
+2
New +$195
WHWK
1365
Whitehawk Therapeutics
WHWK
$183M
$159 ﹤0.01%
77
-4,811
-98% -$7.78K
ANIK icon
1366
Anika Therapeutics
ANIK
$200M
$148 ﹤0.01%
6
-389
-98% -$10.1K
ACET icon
1367
Adicet Bio
ACET
$75.3M
$137 ﹤0.01%
6
-2,084
-100% -$46.6K
ACRS icon
1368
Aclaris Therapeutics
ACRS
$750M
$106 ﹤0.01%
92
-18,227
-99% -$22.4K
BCAB icon
1369
BioAtla
BCAB
$5.64M
$84 ﹤0.01%
1
-344
-100% -$28.8K
FTCI icon
1370
FTC Solar
FTCI
$51.2M
$61 ﹤0.01%
9
-964
-99% -$3.48K
HSTM icon
1371
HealthStream
HSTM
$814M
$57 ﹤0.01%
2
-1,371
-100% -$39.3K
MRNS
1372
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$49 ﹤0.01%
28
-23,670
-100% -$33K
ORGN
1373
DELISTED
Origin Materials
ORGN
$48 ﹤0.01%
1
-1,863
-100% -$67.5K
CUE icon
1374
Cue Biopharma
CUE
$137M
$44 ﹤0.01%
2
-382
-99% -$8.27K
WW
1375
DELISTED
WW International
WW
$41 ﹤0.01%
47
-53,250
-100% -$51.7K

Similar funds

Point72 (DIFC)'s Q3 2024 Portfolio in Review

As of Q3 2024, Point72 (DIFC) held 1,955 positions worth $2.95B, up 5.1% from $2.81B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Point72 (DIFC)'s Q3 2024 filing shows 543 new, 368 increased, 465 reduced and 567 closed positions. Its largest new stake was Adobe: 58,324 shares worth $30.2M. The largest sale was Apple, an estimated $35.9M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 5.7% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Point72 (DIFC)'s largest Q3 2024 buy was Adobe: 58,324 shares worth $30.2M.
  • Point72 (DIFC) added most to Bruker in Q3 2024, an estimated $29.8M increase.
  • Point72 (DIFC)'s biggest Q3 2024 reduction was Visa, cutting an estimated $21M.
  • Point72 (DIFC) fully exited Apple in Q3 2024, selling an estimated $35.9M.
  • Point72 (DIFC)'s ten largest holdings make up 12% of its $2.95B portfolio in Q3 2024.
  • Point72 (DIFC) opened 543 new positions and closed 567 in Q3 2024.
  • Point72 (DIFC)'s portfolio value rose 5.1% quarter-over-quarter to $2.95B.

Based on Point72 (DIFC)'s 13F filing for Q3 2024, filed 14 Nov 2024.